HPV vaccine uptake could be boosted by educating parents
Human papilloma virus (HPV) is the most prevalent of all sexually transmitted infections; globally, four out of five of the world's population will be infected with some form of the virus once in their life. There is a well-established relationship between the virus and the development of many forms of cancer, including cervical and oropharyngeal.
In the UK, vaccine completion rates are about 80%; however in the USA, concordance with vaccination programmes is much lower, with rates of completion less than half that of the UK. The uptake of the vaccine is similarly lower when compared with other regularly endorsed immunisations, such as tetanus.
Using a non-probability convenience sample of 75 parents or legal guardians of children attending a paediatric health clinic in New Jersey, this study examined parental attitudes to general inoculation programmes and their knowledge of the HPV vaccine.
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Cancer Nursing Practice
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests